SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-22-018401
Filing Date
2022-09-13
Accepted
2022-09-13 16:05:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 asln_424b5_-_13092022.htm 424B5 1229872
2 GRAPHIC img184662172_0.jpg GRAPHIC 6863
3 GRAPHIC img184662172_1.jpg GRAPHIC 5929
4 GRAPHIC img184662172_2.jpg GRAPHIC 1021
5 GRAPHIC img184662172_3.jpg GRAPHIC 6847
  Complete submission text file 0000950170-22-018401.txt   1259939
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252575 | Film No.: 221240798
SIC: 2834 Pharmaceutical Preparations